{
    "Trade/Device Name(s)": [
        "ADVIA Centaur FT4 Immunoassay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics",
    "510(k) Number": "K080167",
    "Predicate Device Reference 510(k) Number(s)": [
        "K961510"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEC"
    ],
    "Summary Letter Date": "June 16, 2008",
    "Summary Letter Received Date": "June 17, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1695"
    ],
    "Regulation Name(s)": [
        "Free thyroxine test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Free thyroxine (FT4)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (heparinized)",
        "Plasma (EDTA)"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur System",
        "ADVIA Centaur XP System"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive immunoassay",
        "Chemiluminescent technology"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens ADVIA Centaur FT4 Immunoassay for quantitative determination of free thyroxine in serum or plasma using chemiluminescent immunoassay technology.",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of free thyroxine (FT4) in serum or plasma (heparinized or EDTA) using the ADVIA Centaur and ADVIA Centaur XP Systems; measurements of free thyroxine are used in the diagnosis and treatment of thyroid diseases.",
    "fda_folder": "Clinical Chemistry"
}